Delivery Order SPE2DB24D2102-SPE2DB26FJHKV
- Not listed
- The Defense Logistics Agency awarded a $5,207.80 firm fixed price delivery order to AmerisourceBergen Drug Corp on May 27, 2025, for the supply of Glimepiride 4 mg tablets in quantities of 100. The contract, with an ultimate completion date of May 28, 2025, represents a competitively awarded, non-set-aside procurement with performance location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Glimepiride 4 mg tablets (100 count) with a ceiling value of $2,377.11. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is set for ultimate completion by July 25, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Glimepiride 4 mg tablets in quantities of 100, with a contract value of $9,136.01 and a completion date of September 18, 2025. This is a firm fixed price delivery order with no set-aside designation, awarded under competitive procedures. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under the...
- The U.S. Defense Department's Medical Supply Chain awarded a $7,804.06 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Glimepiride 4 mg tablets in quantities of 100 units. The contract, which is set to be completed by September 16, 2025, utilizes firm fixed pricing and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the delivery order at...
- The Defense Logistics Agency awarded a $2,207.23 delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Glimepiride 4 mg tablets in quantities of 100 units. This is a firm fixed price, competitively awarded contract with an ultimate completion date of September 2, 2025, and represents a child order under AmerisourceBergen's broader pharmaceutical supply agreements with the federal government. The place of performance is the vendor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Glimepiride 4 mg tablets in quantities of 100 units, with a ceiling value of $1,733.37. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is due for completion by September 3, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Glimepiride 4 mg tablets in a quantity of 100 units. This competitively awarded, non-set-aside contract carries a ceiling value of $1,126.05 under firm fixed price terms, with an ultimate completion date of September 9, 2025. The delivery order was issued on September 8, 2025, and will be performed at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 13, 2025, for the supply of Glimepiride 4 mg tablets (100-count units) at a ceiling value of $2,785.80. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by May 14, 2025. The order will be fulfilled from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Glimepiride 4 mg tablets in quantities of 100 units, with a ceiling value of $5,863.25 and a completion date of July 25, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's existing pharmaceutical supply framework. The place of performance is AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $2,375.62 to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets in quantities of 100 units. The contract utilizes firm fixed price pricing and was competitively awarded without a set-aside designation. The order was awarded on October 16, 2025, with an ultimate completion date of October 17, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- SPE2DB24D2102Indefinite Delivery Contract
- SPE2DB24D2102-SPE2DB26FJHKVDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $6,516.15 on October 15, 2025, for the supply of Glimepiride 4 mg tablets in quantities of 100 units. This is a firm fixed price contract with an ultimate completion date of October 16, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal military and veteran healthcare procurement, supplying an extensive portfolio of medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company's significant IDC position with DLA enables it to fulfill pharmaceutical supply requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems on a global basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.5k | 10/15/25 |